Graphene Nanoparticle-Polymer Composite Fabricated by Pulsed Laser Ablation in Liquid

Graphene is an attractive alternative material for diverse applications in electronic devices, fuel cells, biomedical sensors, energy storage, and super-capacitors due to its exceptional thermal, electrical, optical and mechanical properties. This material can be synthesized by many effective methods such as chemical vapor deposition (CVD), micromechanical exfoliation of graphite, and reduction of graphene oxide. Each of these methods has its advantages and disadvantages. This thesis investigates a novel and clean approach to grow graphene directly from bulk graphite by Pulsed Laser Ablation in Liquid, whereas the graphite sheets are immersed in different polymeric solutions (deionized Water, Ethanol, and Toluene) and exposed to two types of lasers (nanosecond and femtosecond lasers). This technique is simple, and fast; a one-step procedure to fabricate pure and stable graphene nanoparticles (GNPs) by short ablation time. It results in controllable-size products, high mass production, high stability, less aggregation, and absence of chemical agents, a known disadvantage observed in other approaches for graphene production. The ablation parameters had been optimized for the best formation efficiency of Pulsed Laser Ablation in Liquid (PLAL) process, after controllably varied trials, which are: 532 nm and 800 nm λ -wavelength for the nanosecond laser and femtosecond laser respectively, with pulse width of 150 ns for ns-laser and 35 fs for fs-laser. The pulse energy are 800 µJ and 250 μJ for the ns-laser and fs-laser respectively, 1kHz is the repetition rate for both lasers. Ablation times are 20 minutes for ns-laser and 1-2 hours for fs-laser, and 5 cm focal length for the focusing lens. Confirming the presence of graphene in solutions or in fabricated thin films is carried out by several characterization techniques including Raman; UV-VISIBLE; atomic force microscopy (AFM); scanning electron microscope (SEM); and transmission electron microscopy (TEM). These techniques allow an insight into the morphological and structural properties of the produced graphene, confirming the purity; particle size uniformity; as well as the number of graphene layers. This thesis attempts to interpret three main aspects of graphene growth: the advantages of the use of the PLAL approach and how it overcomes some of the reported challenges in graphene growth processes; the function of the contribution of different polymers which enhances the formation efficiency, and prevents agglomeration of carbon-based materials of the prepared GNP. Finally, the potential recipe that had been used for growing high quality graphene, with controllable thickness and particle size, was employed in the results section of this thesis

Morphological, structural, electrical, and piezoelectric analysis of hydrothermally grown ZnO nanowires on various substrates

International audienceIn this present work, we have successfully fabricated a piezoelectric structure based on ZnO nanowires (ZnO NWs) using a simple, low cost and environmentally friendly hydrothermal method. This structure forms the basis to fabricate vertically integrated nanogenerator device. This paper attempts to study the effect of several parameters such as the seed layer morphology, seed layer roughness, seed layer annealing temperature, growth temperature, and growth time on three different substrates, which are silicon substrate with a gold & platinum film as lower metal contact, and stainless steel. The structure and morphology of the seed layer and the as-obtained nanowires were characterized using scanning electron microscopy (SEM), high-resolution transmission electron microscopy (HR-TEM), and X-ray diffraction (XRD). SEM analysis shows that the non-aqueous seed solution must be stirred to avoid the formation of the two phases (milky and translucid) and thus the formation of ZnO particles with different sizes and morphologies. In addition, the annealing temperature influences the diameter of the ZnO seed layer and thus ZnO nanowires diameter. This work also shows that the length of the nanowires increases with the growth duration without affecting ZnO diameter (70 ± 30 nm). HR-TEM and XRD studies show the high crystalline quality of the one-dimensional nanomaterials deposited on stainless steel and confirm their high density along the c-axis direction. In this paper, we have also investigated the electrical and piezoelectric performances of the structure obtained. Indeed, the I-V curves exhibit nonlinear and asymmetric electrical characteristics, which confirms the formation of Schottky contacts between the metal and ZnO NWs. According to the piezo-response force microscope, an effective piezoelectric coefficient d33 between 5 and 7 pm/V as a function of the substrate was measured

Effects of Reaction Parameters on the Geometry and Crystallinity of Hydrothermally Synthesized ZnO Nanorods for Bio-Fouling Applications

In this present work, we have successfully synthesized vertical aligned ZnO nanorod arrays (ZnO NRs) on conductive stainless-steel substrate. These ZnO NRs were obtained by using a low temperature, low cost, and eco-friendly hydrothermal approach. The effect of the sol-gel deposited ZnO seed layer on the vertical alignment ZnO NRs has been thoroughly studied. Characterizations of the seed layer and the as-obtained nanorods were investigated using scanning electron microscopy (SEM), X-ray diffraction (XRD), atomic force microscopy (AFM), high-resolution transmission electron microscopy (HR-TEM), and water contact angles (WCA) measurement. SEM analysis shows that these nanorods were grown with a high uniformity and density over the entire substrate. TEM and XRD studies confirmed the hexagonal wurtzite structure of ZnO nanorods. Finally, field immersion tests using the optimized samples were conducted in a coastal sea environment to study biofouling settlement. To the best of our knowledge, there are few articles that investigate the influence of the seed layer deposited on stainless steel on the formation of vertically aligned nanorods for antifouling applications. The novelty of this work is manifested by optimizing the ZnO seed layer to obtain either thick or fine ZnO nanorods (NRs). Moreover, another novelty of this study is the use of the hydrothermal deposition of ZnO NRs on stainless steel for biofouling to replace paints in marine applications

Antifungal and Antibacterial Activities of <em>Musa paradisiaca</em> L. Peel Extract: HPLC Analysis of Phenolic and Flavonoid Contents

In the present study, Melia azedarach wood samples that were treated with the methanolic extract of Musa paradisiaca L. peels were evaluated for their antibacterial and antifungal activities against Agrobacterium tumefaciens, Dickeya solani, Erwinia amylovora, Pseudomonas cichorii, Serratia pylmuthica, Fusarium culmorum, and Rhizoctonia solani. The strongest antibacterial activity was only found against A. tumefaciens (inhibition zone 90 mm), while the other bacterial strains showed resistance to wood that was treated with the extract. Potential antifungal activity against F. culmorum and R. solani was observed; the mycelial growth inhibition percentages reached 68.88% and 94.07%, respectively, in wood samples that were treated with the 3% methanolic extract of M. paradisiaca peel. HPLC analysis demonstrated the presence of seven phenolic compounds and three flavonoid compounds, as their peaks were matched with the standard compounds in a HPLC analysis. The major constituents of phenolic and flavonoid compounds in mg/100 g dry extract (DE) were ellagic acid (16.19), gallic acid (7.73), rutin (973.08), myricetin (11.52), and naringenin (8.47). The results demonstrated the potential effects of banana peel extract as a natural compound that can protect wood from molds while in use

Impact of the International Nosocomial Infection Control Consortium (INICC)’s multidimensional approach on rates of ventilator-associated pneumonia in intensive care units in 22 hospitals of 14 cities of the Kingdom of Saudi Arabia

To analyze the impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and use of INICC Surveillance Online System (ISOS) on ventilator-associated pneumonia (VAP) rates in Saudi Arabia from September 2013 to February 2017. A multicenter, prospective, before–after surveillance study on 14,961 patients in 37 intensive care units (ICUs) of 22 hospitals. During baseline, we performed outcome surveillance of VAP applying the definitions of the CDC/NHSN. During intervention, we implemented the IMA and the ISOS, which included: (1) a bundle of infection prevention practice interventions, (2) education, (3) outcome surveillance, (4) process surveillance, (5) feedback on VAP rates and consequences and (6) performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed using generalized linear mixed models to estimate the effect of intervention. The baseline rate of 7.84 VAPs per 1000 mechanical-ventilator (MV)-days―with 20,927 MV-days and 164 VAPs―, was reduced to 4.74 VAPs per 1000 MV-days―with 118,929 MV-days and 771 VAPs―, accounting for a 39% rate reduction (IDR 0.61; 95% CI 0.5–0.7; P 0.001). Implementing the IMA was associated with significant reductions in VAP rates in ICUs of Saudi Arabia

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

•We report INICC device-associated module data of 50 countries from 2010-2015.•We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.•DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.•Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically

Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

International audienceBackground: Current management practices and outcomes in weaning from invasive mechanical ventilation are poorly understood. We aimed to describe the epidemiology, management, timings, risk for failure, and outcomes of weaning in patients requiring at least 2 days of invasive mechanical ventilation. Methods: WEAN SAFE was an international, multicentre, prospective, observational cohort study done in 481 intensive care units in 50 countries. Eligible participants were older than 16 years, admitted to a participating intensive care unit, and receiving mechanical ventilation for 2 calendar days or longer. We defined weaning initiation as the first attempt to separate a patient from the ventilator, successful weaning as no reintubation or death within 7 days of extubation, and weaning eligibility criteria based on positive end-expiratory pressure, fractional concentration of oxygen in inspired air, and vasopressors. The primary outcome was the proportion of patients successfully weaned at 90 days. Key secondary outcomes included weaning duration, timing of weaning events, factors associated with weaning delay and weaning failure, and hospital outcomes. This study is registered with ClinicalTrials.gov, NCT03255109. Findings: Between Oct 4, 2017, and June 25, 2018, 10 232 patients were screened for eligibility, of whom 5869 were enrolled. 4523 (77·1%) patients underwent at least one separation attempt and 3817 (65·0%) patients were successfully weaned from ventilation at day 90. 237 (4·0%) patients were transferred before any separation attempt, 153 (2·6%) were transferred after at least one separation attempt and not successfully weaned, and 1662 (28·3%) died while invasively ventilated. The median time from fulfilling weaning eligibility criteria to first separation attempt was 1 day (IQR 0–4), and 1013 (22·4%) patients had a delay in initiating first separation of 5 or more days. Of the 4523 (77·1%) patients with separation attempts, 2927 (64·7%) had a short wean (≤1 day), 457 (10·1%) had intermediate weaning (2–6 days), 433 (9·6%) required prolonged weaning (≥7 days), and 706 (15·6%) had weaning failure. Higher sedation scores were independently associated with delayed initiation of weaning. Delayed initiation of weaning and higher sedation scores were independently associated with weaning failure. 1742 (31·8%) of 5479 patients died in the intensive care unit and 2095 (38·3%) of 5465 patients died in hospital. Interpretation: In critically ill patients receiving at least 2 days of invasive mechanical ventilation, only 65% were weaned at 90 days. A better understanding of factors that delay the weaning process, such as delays in weaning initiation or excessive sedation levels, might improve weaning success rates. Funding: European Society of Intensive Care Medicine, European Respiratory Society

Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

Background Current management practices and outcomes in weaning from invasive mechanical ventilation are poorly understood. We aimed to describe the epidemiology, management, timings, risk for failure, and outcomes of weaning in patients requiring at least 2 days of invasive mechanical ventilation. Methods WEAN SAFE was an international, multicentre, prospective, observational cohort study done in 481 intensive care units in 50 countries. Eligible participants were older than 16 years, admitted to a participating intensive care unit, and receiving mechanical ventilation for 2 calendar days or longer. We defined weaning initiation as the first attempt to separate a patient from the ventilator, successful weaning as no reintubation or death within 7 days of extubation, and weaning eligibility criteria based on positive end-expiratory pressure, fractional concentration of oxygen in inspired air, and vasopressors. The primary outcome was the proportion of patients successfully weaned at 90 days. Key secondary outcomes included weaning duration, timing of weaning events, factors associated with weaning delay and weaning failure, and hospital outcomes. This study is registered with ClinicalTrials.gov, NCT03255109. Findings Between Oct 4, 2017, and June 25, 2018, 10 232 patients were screened for eligibility, of whom 5869 were enrolled. 4523 (77·1%) patients underwent at least one separation attempt and 3817 (65·0%) patients were successfully weaned from ventilation at day 90. 237 (4·0%) patients were transferred before any separation attempt, 153 (2·6%) were transferred after at least one separation attempt and not successfully weaned, and 1662 (28·3%) died while invasively ventilated. The median time from fulfilling weaning eligibility criteria to first separation attempt was 1 day (IQR 0–4), and 1013 (22·4%) patients had a delay in initiating first separation of 5 or more days. Of the 4523 (77·1%) patients with separation attempts, 2927 (64·7%) had a short wean (≤1 day), 457 (10·1%) had intermediate weaning (2–6 days), 433 (9·6%) required prolonged weaning (≥7 days), and 706 (15·6%) had weaning failure. Higher sedation scores were independently associated with delayed initiation of weaning. Delayed initiation of weaning and higher sedation scores were independently associated with weaning failure. 1742 (31·8%) of 5479 patients died in the intensive care unit and 2095 (38·3%) of 5465 patients died in hospital. Interpretation In critically ill patients receiving at least 2 days of invasive mechanical ventilation, only 65% were weaned at 90 days. A better understanding of factors that delay the weaning process, such as delays in weaning initiation or excessive sedation levels, might improve weaning success rates

Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

Background: Current management practices and outcomes in weaning from invasive mechanical ventilation are poorly understood. We aimed to describe the epidemiology, management, timings, risk for failure, and outcomes of weaning in patients requiring at least 2 days of invasive mechanical ventilation. Methods: WEAN SAFE was an international, multicentre, prospective, observational cohort study done in 481 intensive care units in 50 countries. Eligible participants were older than 16 years, admitted to a participating intensive care unit, and receiving mechanical ventilation for 2 calendar days or longer. We defined weaning initiation as the first attempt to separate a patient from the ventilator, successful weaning as no reintubation or death within 7 days of extubation, and weaning eligibility criteria based on positive end-expiratory pressure, fractional concentration of oxygen in inspired air, and vasopressors. The primary outcome was the proportion of patients successfully weaned at 90 days. Key secondary outcomes included weaning duration, timing of weaning events, factors associated with weaning delay and weaning failure, and hospital outcomes. This study is registered with ClinicalTrials.gov, NCT03255109. Findings: Between Oct 4, 2017, and June 25, 2018, 10 232 patients were screened for eligibility, of whom 5869 were enrolled. 4523 (77·1%) patients underwent at least one separation attempt and 3817 (65·0%) patients were successfully weaned from ventilation at day 90. 237 (4·0%) patients were transferred before any separation attempt, 153 (2·6%) were transferred after at least one separation attempt and not successfully weaned, and 1662 (28·3%) died while invasively ventilated. The median time from fulfilling weaning eligibility criteria to first separation attempt was 1 day (IQR 0-4), and 1013 (22·4%) patients had a delay in initiating first separation of 5 or more days. Of the 4523 (77·1%) patients with separation attempts, 2927 (64·7%) had a short wean (≤1 day), 457 (10·1%) had intermediate weaning (2-6 days), 433 (9·6%) required prolonged weaning (≥7 days), and 706 (15·6%) had weaning failure. Higher sedation scores were independently associated with delayed initiation of weaning. Delayed initiation of weaning and higher sedation scores were independently associated with weaning failure. 1742 (31·8%) of 5479 patients died in the intensive care unit and 2095 (38·3%) of 5465 patients died in hospital. Interpretation: In critically ill patients receiving at least 2 days of invasive mechanical ventilation, only 65% were weaned at 90 days. A better understanding of factors that delay the weaning process, such as delays in weaning initiation or excessive sedation levels, might improve weaning success rates. Funding: European Society of Intensive Care Medicine, European Respiratory Society